Abstract:Abstract Numerous malignant cells are resistant to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cytotoxicity, limiting value of TRAIL as an antitumor therapeutics. Combination of TRAIL with other agents is a promising strategy to overcome TRAIL resistance. Wogonin (5, 7-dihydroxy-8-methoxyflavone), a flavonoid originated from the root of the medicinal herb Scutellaria baicalensis Georgi, has been shown to enhance TRAIL-induced apoptosis in malignant cells in in vitro studies. However, whether wogonin enhances TRAIL's antitumor activity in vivo has never been studied. In this study, we first found that wogonin sensitized a variety of cancer cells including A549, HeLa and SKOV3 to TRAIL-induced apoptosis, as indicated by increased annexin V staining and enhanced activation of caspase-8 and -3 in TRAIL and wogonin cotreated cells, whereas having marginal effect on non-transformed bronchial epithelial cells and cervical epithelial cells. Then the effect of combination of TRAIL and wogonin was tested in a xenografted tumor model with A549 cells in nude mice. The results show that wogonin greatly enhanced TRAIL-induced suppression of tumor growth, which was accompanied with increased apoptosis in tumor tissues determined by a terminal deoxynucleotidyl-transferase -mediated dUTP nick-end labeling (TUNEL) assay. The protein levels of X-linked inhibitor of apoptosis protein (XIAP) and cellular inhibitor of apoptosis protein 1 and 2 (cIAP-1 and cIAP-2) were markedly reduced in both cultured cells and xenografted tumor tissues with co-treatment of wogonin and TRAIL. The down-regulation of these antiapoptotic proteins was likely mediated through proteasomal degradation and involved intracellular H2O2, as wogonin robustly induced H2O2 accumulation in A549 cells and the reactive oxygen species scavengers butylated hydroxyanisole (BHA) and N-acetyl-L-cysteine (NAC) and the proteasome inhibitor MG132 restored the expression of these antiapoptotic proteins and suppressed cytotoxicity in cells co-treated with wogonin and TRAIL. These results provide important in vivo evidence supporting the application of wogonin as TRAIL sensitizer for cancer therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3724. doi:1538-7445.AM2012-3724

Wogonin induces apoptosis in macrophages by exhibiting cytotoxic and genotoxic effects

Anti-Inflammatory Effect of Wogonin on RAW 264.7 Mouse Macrophages Induced with Polyinosinic-Polycytidylic Acid

Changes in mitochondrial membrane potential and reactive oxygen species during wogonin-induced cell death in human hepatoma cells

Effect of Magnetic Nanoparticles on Apoptosis and Cell Cycle Induced by Wogonin in Raji Cells

Effects of Wogonin on the Levels of Cytokines and Functions of Leukocytes Associated with NF-kappa B Expression in Sprague-Dawley Rats.

Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721.

Wogonin Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells by Activation of Unfolded Protein Response and Inactivation of AKT.

Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells

Wogonin Accelerates Hematoma Clearance and Improves Neurological Outcome Via the PPAR-γ Pathway after Intracerebral Hemorrhage

Wogonin Triggers Apoptosis in Human Osteosarcoma U-2 OS Cells Through the Endoplasmic Reticulum Stress, Mitochondrial Dysfunction and Caspase-3-dependent Signaling Pathways

Wogonin-enhanced reactive oxygen species-induced apoptosis and potentiated cytotoxic effects of chemotherapeutic agents by suppression Nrf2-mediated signaling in HepG2 cells

Wogonin Induced Differentiation and G1 Phase Arrest of Human U-937 Leukemia Cells Via PKCdelta Phosphorylation.

Abstract 3724: Wogonin Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand's Antitumor Activity in Vivo Through H2O2-mediated Downregulation of X-linked Inhibitor of Apoptosis Protein and Cellular Inhibitor of Apoptosis Protein 1 and 2

Effects of wogonin on the mechanism of melanin synthesis in A375 cells

Developmental Toxicity and Genotoxicity Studies of Wogonin.

Different Apoptotic Effects of Wogonin Via Induction of H2o2 Generation and Ca2+ Overload in Malignant Hepatoma and Normal Hepatic Cells

Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins

Catalase Suppression‐mediated H2O2 Accumulation in Cancer Cells by Wogonin Effectively Blocks Tumor Necrosis Factor‐induced NF‐κB Activation and Sensitizes Apoptosis

Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis

NF- κ B and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis

Wogonin Inhibits the Proliferation and Invasion, and Induces the Apoptosis of HepG2 and Bel7402 HCC Cells Through NF‑κB/Bcl-2, EGFR and EGFR Downstream ERK/AKT Signaling.